This page is reference information only. Most compounds described here are research chemicals, not FDA-approved medications. MyTRT does not sell, recommend, or endorse the use of these substances. Always consult a qualified physician.
NSI-189 Phosphate
Neurogenic Research Compound
/WHAT_IT_IS
NSI-189 is a neurogenic compound developed to stimulate neurogenesis in the hippocampus and has been studied for depression and cognitive impairment.
/USAGE
Investigated for its potential in treating major depressive disorder (MDD) and cognitive decline. Also explored for stroke recovery.
/MECHANISM_OF_ACTION
Stimulates neurogenesis and increases hippocampal volume. May modulate BDNF and other neurotrophic pathways.
Reported Benefits
- +Mood elevation
- +Cognitive support
- +Potential neurogenesis
Reported Side Effects
- −Mild headaches
- −Fatigue
- −GI discomfort (rare)
/STACKED_WITH
/RESEARCH_NOTES
Demonstrated improvements in depression symptoms and cognitive performance in early-stage clinical trials.
Browse all 89 in the app.
MyTRT's in-app library has the same 89 peptide entries plus dosing notes, stack builders, and the ability to log them alongside your TRT protocol.